Grade: F — Major Red Flags
Framework: Schilit *Financial Shenanigans* + Beneish M-Score + forensic accounting principles
Data: SEC EDGAR 10-K (Filed 2025-08-08, FY ended June 30, 2025) + Yahoo Finance
Auditor: Ernst & Young LLP — Unqualified opinion
Note: Critical audit matters and detailed auditor report referenced via Exhibit 99.1
One-line verdict: Clorox earns an F grade from the same consumer staples balance sheet pattern: cash-to-debt coverage of 6% and goodwill+intangibles at 559% of equity. The underlying business is recovering well — gross margin rebounded from 35.8% to 45.2% over three years after the 2023 cyberattack that devastated operations, CFFO surged 41% to $981M, and net income nearly tripled to $810M. The M-Score of -2.47 is clean. The structural concern is Clorox's tiny equity base ($321M) relative to $2.9B in debt, driven by decades of share repurchases. The filing warns about an ongoing ERP implementation that could affect internal controls, and AR growth of 22.2% against flat revenue is a signal to watch.
| Metric | Result |
|---|---|
| ❌ Red Flags | **2** (Cash-to-debt, goodwill+intangibles vs equity) |
| ⚠️ Watch Items | **1** (AR growth 22.2% vs revenue 0.2%) |
| Checks Completed | **17/18** (1 N/A: impairment data) |
| Beneish M-Score | **-2.47** (clean; threshold is -2.22) |
| Auditor | Ernst & Young LLP — Unqualified opinion |
Recovery from the 2023 Cyberattack
Clorox suffered a major cyberattack in August 2023 that forced the company to take systems offline and caused "significant operational disruption." The three-year trend shows the recovery path:
| Metric | FY2023 | FY2024 | FY2025 | Trend |
|---|---|---|---|---|
| Net Sales | $7.4B | $7.1B | $7.1B | Revenue still below pre-attack level |
| Net Income | $149M | $280M | $810M | Strong recovery |
| Gross Margin | 39.4% | 43.0% | 45.2% | Robust expansion |
| Net Margin | 2.0% | 3.9% | 11.4% | Normalizing |
| CFFO | $1,158M | $695M | $981M | Volatile but recovering |
Revenue is essentially flat at $7.1B — the company has not yet recovered the $300M in sales lost from FY2023's $7.4B. But profitability has recovered dramatically: gross margin expanded nearly 10 percentage points from the FY2022 trough of 35.8% to 45.2%, driven by pricing, cost management, and operational normalization.
Cash Flow: Volatile but Now Strong
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Operating Cash Flow | $1,158M | $695M | $981M |
| Net Income | $149M | $280M | $810M |
| **CFFO / Net Income** | **7.77** | **2.48** | **1.21** |
| Free Cash Flow | $930M | $483M | $761M |
| Cash | $367M | $202M | $167M |
| Total Debt | $2,924M | $2,903M | $2,880M |
The CFFO/NI ratio normalizing from 7.77 to 1.21 reflects the denominator (net income) recovering rather than the numerator (cash flow) deteriorating. FY2023's elevated ratio was caused by the cyberattack depressing net income while working capital releases generated strong cash flow.
FCF of $761M is 94% of net income — clean cash conversion. Debt has been slowly reduced from $2,924M to $2,880M over three years, but the pace is glacial.
The 18-Point Screening
Revenue Quality
| # | Check | Result | Detail |
|---|---|---|---|
| A1 | DSO Change | ✅ | DSO 41 days, +7 days YoY |
| A2 | AR vs Revenue Growth | ⚠️ | AR growth 22.2% vs revenue 0.2% |
| A3 | Revenue vs CFFO | ✅ | Revenue +0.2%, CFFO +41.2% |
A2 — AR surging on flat revenue. DSO jumped from 34 to 41 days. The filing mentions the company is implementing a new ERP system, which could explain timing differences in receivable recognition. But a 22% AR increase with 0.2% revenue growth demands monitoring in FY2026. If the pattern persists, it could indicate channel stuffing or loosening credit terms.
Expense Quality
| # | Check | Result | Detail |
|---|---|---|---|
| B1 | Inventory vs COGS | ✅ | Inventory -17.9% vs COGS -3.8% |
| B2 | CapEx vs Revenue | ✅ | CapEx +3.8% vs revenue +0.2% |
| B3 | SG&A Ratio | ✅ | SG&A/Gross Profit = 58.9% |
| B4 | Gross Margin | ✅ | 45.2%, +2.3pp |
Inventory declining 18% while revenue is flat is a strong signal — the company is working through excess stock built up during the cyber recovery period. Gross margin expansion of 2.3 percentage points in a single year reflects pricing power and cost discipline.
Cash Flow Quality
| # | Check | Result | Detail |
|---|---|---|---|
| C1 | CFFO vs Net Income | ✅ | CFFO/NI = 1.21 |
| C2 | Free Cash Flow | ✅ | FCF $761M, FCF/NI = 0.94 |
| C3 | Accruals Ratio | ✅ | -3.1% |
| C4 | Cash vs Debt | ❌ | Cash $167M covers only 6% of debt $2.9B |
C4 is structural. Clorox maintains minimal cash, relying on revolving credit facilities and consistent cash generation. With $981M annual CFFO against $2.9B debt, the company could theoretically retire all debt in three years.
Balance Sheet
| # | Check | Result | Detail |
|---|---|---|---|
| D1 | Goodwill + Intangibles | ❌ | $1.8B = 559% of equity |
| D2 | Leverage | ✅ | Debt/EBITDA = 2.1x |
| D3 | Soft Asset Growth | ✅ | Other assets +2.4% vs revenue +0.2% |
| D4 | Asset Impairment | — | No write-off data |
D1 — same as Colgate: equity is artificially low from cumulative buybacks. Debt/EBITDA of 2.1x and interest coverage of 13.4x confirm manageable leverage.
Acquisition Risk
| # | Check | Result | Detail |
|---|---|---|---|
| E1 | Serial Acquirer FCF | ✅ | FCF after acquisitions positive |
| E2 | Goodwill Surge | ✅ | Goodwill+Intangibles -6% YoY |
Manipulation Score
| # | Check | Result | Detail |
|---|---|---|---|
| F1 | Beneish M-Score | ✅ | -2.47 (clean) |
The DSRI component of 1.22 reflects the DSO jump but all other components are benign.
Key Risks from the 10-K
1. ERP Implementation Risk
The filing discloses: "The Company is in the process of implementing a new enterprise resource planning" system. ERP transitions are notorious for causing temporary internal control weaknesses, data migration errors, and financial reporting disruptions. This may explain the AR spike.
2. Cyberattack Legacy
While operations have recovered, the 2023 cyberattack demonstrated that Clorox's systems were vulnerable. The filing warns about "cybersecurity incidents" as a material risk. Revenue has not fully recovered to pre-attack levels.
3. Divestiture Risk
The filing warns the company "has divested and may, in the future, divest certain assets, businesses or brands" and that such divestitures "could affect the profitability of the Company." Portfolio simplification can create unexpected gaps.
4. Z-Score in Grey Zone
At 1.36, the Z-Score sits in the grey zone — primarily driven by the tiny equity base and negative working capital. This is a statistical artifact of the buyback strategy, but it means the company has limited balance sheet buffer against unexpected shocks.
Summary
Grade: F, driven by structural balance sheet engineering.
Clorox is operationally healthy and recovering strongly from the 2023 cyberattack: gross margins at 45.2%, CFFO/NI of 1.21, FCF of $761M, and a clean M-Score of -2.47. The two red flags — cash-to-debt and goodwill-to-equity — are consequences of decades of share repurchases that have reduced equity to $321M. The genuine concerns are the DSO spike (+7 days on flat revenue, watch for channel stuffing), the ongoing ERP implementation risk, and the Z-Score of 1.36 that leaves little room for error. The business is sound; the capital structure is aggressive by design.
**Disclaimer**: This report is based on Clorox's FY2025 10-K filed with SEC EDGAR on August 8, 2025. This is NOT investment advice.
Data: SEC EDGAR 10-K + Yahoo Finance
Auditor: Ernst & Young LLP (Unqualified opinion)
Fiscal year ended: June 30, 2025